Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis

J K Ellington1, M Harris, L Webb

  • 1Department of Orthopaedic Surgery,Wake Forest University School of Medicine, Winston Salem, North Carolina 27103, USA.

Insights

Viable Staphylococcus aureus (Staph. aureus) can be released from dead osteoblasts, the bone-forming cells. These released bacteria can then successfully reinfect new osteoblasts, contributing to osteomyelitis.

Area of Science:

  • Microbiology
  • Cell Biology
  • Orthopedics

Background:

  • Staphylococcus aureus is a primary cause of human osteomyelitis.
  • This bacterium invades and persists within osteoblasts.
  • The fate of intracellular bacteria after host cell death is unknown.

Purpose of the Study:

  • To investigate the viability and infectivity of Staphylococcus aureus released from dead or dying osteoblasts.
  • To understand the intracellular survival and release mechanism of Staph. aureus in osteomyelitis.

Main Methods:

  • Human osteoblasts were infected with Staph. aureus.
  • Osteoblasts were subsequently lysed or trypsinized to release intracellular bacteria.
  • Released bacteria were cultured, quantified, and used to infect new osteoblast cultures.

Main Results:

  • Equivalent numbers of Staph. aureus were recovered using both lysis and trypsinization methods.
  • Staph. aureus recovered from infected osteoblasts (at time zero and 24 hours) could successfully invade a second osteoblast culture.
  • These findings demonstrate the viability and reinfectivity of bacteria released from dead osteoblasts.

Conclusions:

  • Dead or dying osteoblasts release viable Staphylococcus aureus.
  • Staph. aureus released from compromised osteoblasts can re-initiate infection in new host cells.
  • This mechanism may play a significant role in the persistence and recurrence of osteomyelitis.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...